Z79 — Long term (current) drug therapy
Is Z79 billable?
No — Z79 is a non-billable header code. Z79 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 32 billable codes beneath Z79.
Billable codes under this header
- Z79.1Long term (current) use of non-steroidal anti-inflammatories (NSAID)
- Z79.2Long term (current) use of antibiotics
- Z79.3Long term (current) use of hormonal contraceptives
- Z79.4Long term (current) use of insulin
- Z79.01Long term (current) use of anticoagulants
- Z79.02Long term (current) use of antithrombotics/antiplatelets
- Z79.51Long term (current) use of inhaled steroids
- Z79.52Long term (current) use of systemic steroids
- Z79.60Long term (current) use of unspecified immunomodulators and immunosuppressants
- Z79.61Long term (current) use of immunomodulator
- Z79.64Long term (current) use of myelosuppressive agent
- Z79.69Long term (current) use of other immunomodulators and immunosuppressants
- Z79.82Long term (current) use of aspirin
- Z79.83Long term (current) use of bisphosphonates
- Z79.84Long term (current) use of oral hypoglycemic drugs
- Z79.85Long-term (current) use of injectable non-insulin antidiabetic drugs
- Z79.620Long term (current) use of immunosuppressive biologic
- Z79.621Long term (current) use of calcineurin inhibitor
- Z79.622Long term (current) use of Janus kinase inhibitor
- Z79.623Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
- Z79.624Long term (current) use of inhibitors of nucleotide synthesis
- Z79.630Long term (current) use of alkylating agent
- Z79.631Long term (current) use of antimetabolite agent
- Z79.632Long term (current) use of antitumor antibiotic
- Z79.633Long term (current) use of mitotic inhibitor
- Z79.634Long term (current) use of topoisomerase inhibitor
- Z79.810Long term (current) use of selective estrogen receptor modulators (SERMs)
- Z79.811Long term (current) use of aromatase inhibitors
- Z79.818Long term (current) use of other agents affecting estrogen receptors and estrogen levels
- Z79.890Hormone replacement therapy
- Z79.891Long term (current) use of opiate analgesic
- Z79.899Other long term (current) drug therapy
Z79 at a glance
| Code | Z79 |
|---|---|
| Description | Long term (current) drug therapy |
| Billable | No — header code |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Excludes2 — not included here
The conditions below are not part of Z79, but a patient may have both at the same time. When documentation supports it, Z79 and the excluded code may both be reported.
Code also
Two codes may be needed to describe the condition fully. Whether Z79 is sequenced first depends on the reason for the encounter.
- any therapeutic drug level monitoring (Z51.81)
Includes
Conditions classified to Z79.
- long term (current) drug use for prophylactic purposes
Code also — inherited from Z77-Z99
Two codes may be needed to describe the condition fully. Whether Z79 is sequenced first depends on the reason for the encounter.
- any follow-up examination (Z08-Z09)
What codes fall under Z79? (8)
- Z79.0Long term (current) use of anticoagulants and antithrombotics/antiplateletsnot billable
- Z79.1Long term (current) use of non-steroidal anti-inflammatories (NSAID)
- Z79.2Long term (current) use of antibiotics
- Z79.3Long term (current) use of hormonal contraceptives
- Z79.4Long term (current) use of insulin
- Z79.5Long term (current) use of steroidsnot billable
- Z79.6Long term (current) use of immunomodulators and immunosuppressantsnot billable
- Z79.8Other long term (current) drug therapynot billable
How long has Z79 existed?
Z79 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.